{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T15:50:03Z","timestamp":1780588203881,"version":"3.54.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T00:00:00Z","timestamp":1585180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T00:00:00Z","timestamp":1585180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s12185-020-02863-4","type":"journal-article","created":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T03:02:48Z","timestamp":1585191768000},"page":"877-887","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Nitrosourea, etoposide and cyclophosphamide followed by autologous stem cell transplantation for pediatric lymphoma patients"],"prefix":"10.1007","volume":"111","author":[{"given":"Jung Yoon","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1009-6002","authenticated-orcid":false,"given":"Hyoung Jin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Yul","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Taek","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Young","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,26]]},"reference":[{"issue":"19","key":"2863_CR1","doi-asserted-by":"publisher","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","volume":"117","author":"E Campo","year":"2011","unstructured":"Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 2011;117(19):5019\u201332.","journal-title":"Blood"},{"issue":"19","key":"2863_CR2","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1056\/NEJM199605093341906","volume":"334","author":"JT Sandlund","year":"1996","unstructured":"Sandlund JT, Downing JR, Crist WM. Non-Hodgkin\u2019s lymphoma in childhood. N Engl J Med. 1996;334(19):1238\u201348.","journal-title":"N Engl J Med"},{"issue":"6","key":"2863_CR3","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/j.1365-2141.2008.07144.x","volume":"141","author":"M Gerrard","year":"2008","unstructured":"Gerrard M, Cairo MS, Weston C, Auperin A, Pinkerton R, Lambilliote A, et al. Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin\u2019s lymphoma: results of the FAB\/LMB 96 international study. Br J Haematol. 2008;141(6):840\u20137.","journal-title":"Br J Haematol"},{"issue":"3","key":"2863_CR4","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/pbc.21817","volume":"52","author":"EJ Lowe","year":"2009","unstructured":"Lowe EJ, Sposto R, Perkins SL, Gross TG, Finlay J, Zwick D, et al. Intensive chemotherapy for systemic anaplastic large cell lymphoma in children and adolescents: final results of Children\u2019s Cancer Group Study 5941. Pediatr Blood Cancer. 2009;52(3):335\u20139.","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"2863_CR5","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1182\/blood-2006-07-036673","volume":"109","author":"C Patte","year":"2007","unstructured":"Patte C, Auperin A, Gerrard M, Michon J, Pinkerton R, Sposto R, et al. Results of the randomized international FAB\/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients. Blood. 2007;109(7):2773\u2013800.","journal-title":"Blood"},{"issue":"2","key":"2863_CR6","first-page":"416","volume":"95","author":"A Reiter","year":"2000","unstructured":"Reiter A, Schrappe M, Ludwig WD, Tiemann M, Parwaresch R, Zimmermann M, et al. Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Blood. 2000;95(2):416\u201321.","journal-title":"Blood"},{"issue":"26","key":"2863_CR7","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.1200\/JCO.2011.41.1819","volume":"30","author":"SL Wolden","year":"2012","unstructured":"Wolden SL, Chen L, Kelly KM, Herzog P, Gilchrist GS, Thomson J, et al. Long-term results of CCG 5942: a randomized comparison of chemotherapy with and without radiotherapy for children with Hodgkin\u2019s lymphoma\u2014a report from the Children\u2019s Oncology Group. J Clin Oncol. 2012;30(26):3174\u201380.","journal-title":"J Clin Oncol"},{"issue":"27","key":"2863_CR8","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1200\/JCO.2014.59.5827","volume":"33","author":"V Minard-Colin","year":"2015","unstructured":"Minard-Colin V, Brugieres L, Reiter A, Cairo MS, Gross TG, Woessmann W, et al. Non-Hodgkin lymphoma in children and adolescents: progress through effective collaboration, current knowledge, and challenges ahead. J Clin Oncol. 2015;33(27):2963\u201374.","journal-title":"J Clin Oncol"},{"issue":"27","key":"2863_CR9","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1200\/JCO.2014.59.4853","volume":"33","author":"C Mauz-Korholz","year":"2015","unstructured":"Mauz-Korholz C, Metzger ML, Kelly KM, Schwartz CL, Castellanos ME, Dieckmann K, et al. Pediatric Hodgkin Lymphoma. J Clin Oncol. 2015;33(27):2975\u201385.","journal-title":"J Clin Oncol"},{"issue":"7","key":"2863_CR10","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1182\/blood-2006-07-036665","volume":"109","author":"MS Cairo","year":"2007","unstructured":"Cairo MS, Gerrard M, Sposto R, Auperin A, Pinkerton CR, Michon J, et al. Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents. Blood. 2007;109(7):2736\u201343.","journal-title":"Blood"},{"issue":"9","key":"2863_CR11","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1200\/JCO.2001.19.9.2390","volume":"19","author":"NL Kobrinsky","year":"2001","unstructured":"Kobrinsky NL, Sposto R, Shah NR, Anderson JR, DeLaat C, Morse M, et al. Outcomes of treatment of children and adolescents with recurrent non-Hodgkin's lymphoma and Hodgkin\u2019s disease with dexamethasone, etoposide, cisplatin, cytarabine, and l-asparaginase, maintenance chemotherapy, and transplantation: Children\u2019s Cancer Group Study CCG-5912. J Clin Oncol. 2001;19(9):2390\u20136.","journal-title":"J Clin Oncol"},{"issue":"10","key":"2863_CR12","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1016\/j.ejca.2005.03.010","volume":"41","author":"J Lee","year":"2005","unstructured":"Lee J, Park YH, Kim WS, Lee SS, Ryoo BY, Yang SH, et al. Extranodal nasal type NK\/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy. Eur J Cancer. 2005;41(10):1402\u20138.","journal-title":"Eur J Cancer"},{"issue":"1","key":"2863_CR13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/ajcp\/aqv010","volume":"145","author":"Y Huang","year":"2016","unstructured":"Huang Y, Xie J, Ding Y, Zhou X. Extranodal natural killer\/T-Cell lymphoma in children and adolescents: a report of 17 cases in China. Am J Clin Pathol. 2016;145(1):46\u2013544.","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"2863_CR14","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.bbmt.2015.02.005","volume":"21","author":"YB Chen","year":"2015","unstructured":"Chen YB, Lane AA, Logan B, Zhu X, Akpek G, Aljurf M, et al. Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2015;21(6):1046\u201353.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"2863_CR15","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.bbmt.2010.07.002","volume":"17","author":"RE Harris","year":"2011","unstructured":"Harris RE, Termuhlen AM, Smith LM, Lynch J, Henry MM, Perkins SL, et al. Autologous peripheral blood stem cell transplantation in children with refractory or relapsed lymphoma: results of Children\u2019s Oncology Group study A5962. Biol Blood Marrow Transplant. 2011;17(2):249\u201358.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"2863_CR16","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1200\/JCO.1989.7.2.186","volume":"7","author":"SB Murphy","year":"1989","unstructured":"Murphy SB, Fairclough DL, Hutchison RE, Berard CW. Non-Hodgkin\u2019s lymphomas of childhood: an analysis of the histology, staging, and response to treatment of 338 cases at a single institution. J Clin Oncol. 1989;7(2):186\u201393.","journal-title":"J Clin Oncol"},{"issue":"4","key":"2863_CR17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","volume":"118","author":"GB McDonald","year":"1993","unstructured":"McDonald GB, Hinds MS, Fisher LD, Schoch HG, Wolford JL, Banaji M, et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med. 1993;118(4):255\u201367.","journal-title":"Ann Intern Med"},{"issue":"6","key":"2863_CR18","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","volume":"44","author":"RJ Jones","year":"1987","unstructured":"Jones RJ, Lee KS, Beschorner WE, Vogel VG, Grochow LB, Braine HG, et al. Venoocclusive disease of the liver following bone marrow transplantation. Transplantation. 1987;44(6):778\u201383.","journal-title":"Transplantation"},{"issue":"4","key":"2863_CR19","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/MD.0b013e31818193bb","volume":"87","author":"D Montani","year":"2008","unstructured":"Montani D, Achouh L, Dorfmuller P, Le Pavec J, Sztrymf B, Tcherakian C, et al. Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology. Medicine (Baltimore). 2008;87(4):220\u201333.","journal-title":"Medicine (Baltimore)"},{"issue":"25 Suppl","key":"2863_CR20","doi-asserted-by":"publisher","first-page":"D34","DOI":"10.1016\/j.jacc.2013.10.029","volume":"62","author":"G Simonneau","year":"2013","unstructured":"Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 Suppl):D34\u201341.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2863_CR21","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/sj.bmt.1705727","volume":"40","author":"L Scrucca","year":"2007","unstructured":"Scrucca L, Santucci A, Aversa F. Competing risk analysis using R: an easy guide for clinicians. Bone Marrow Transplant. 2007;40(4):381\u20137.","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"2863_CR22","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1038\/bmt.2009.359","volume":"45","author":"L Scrucca","year":"2010","unstructured":"Scrucca L, Santucci A, Aversa F. Regression modeling of competing risk using R: an in depth guide for clinicians. Bone Marrow Transplant. 2010;45(9):1388\u201395.","journal-title":"Bone Marrow Transplant"},{"issue":"8617","key":"2863_CR23","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/S0140-6736(88)92596-2","volume":"2","author":"PS Gaynon","year":"1988","unstructured":"Gaynon PS, Steinherz PG, Bleyer WA, Ablin AR, Albo VC, Finklestein JZ, et al. Intensive therapy for children with acute lymphoblastic leukaemia and unfavourable presenting features. Early conclusions of study CCG-106 by the Childrens Cancer Study Group. Lancet. 1988;2(8617):921\u20134.","journal-title":"Lancet"},{"issue":"1","key":"2863_CR24","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1200\/JCO.1989.7.1.92","volume":"7","author":"AT Meadows","year":"1989","unstructured":"Meadows AT, Sposto R, Jenkin RD, Kersey JH, Chilcote RR, Siegel SE, et al. Similar efficacy of 6 and 18 months of therapy with four drugs (COMP) for localized non-Hodgkin\u2019s lymphoma of children: a report from the Childrens Cancer Study Group. J Clin Oncol. 1989;7(1):92\u20139.","journal-title":"J Clin Oncol"},{"issue":"4","key":"2863_CR25","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1200\/JCO.2010.33.3369","volume":"30","author":"MS Cairo","year":"2012","unstructured":"Cairo MS, Sposto R, Gerrard M, Auperin A, Goldman SC, Harrison L, et al. Advanced stage, increased lactate dehydrogenase, and primary site, but not adolescent age (\u2265 15 years), are associated with an increased risk of treatment failure in children and adolescents with mature B-cell non-Hodgkin\u2019s lymphoma: results of the FAB LMB 96 study. J Clin Oncol. 2012;30(4):387\u201393.","journal-title":"J Clin Oncol"},{"issue":"33","key":"2863_CR26","doi-asserted-by":"publisher","first-page":"5254","DOI":"10.1200\/JCO.2007.11.3159","volume":"25","author":"L Mussolin","year":"2007","unstructured":"Mussolin L, Pillon M, Conter V, Piglione M, Lo Nigro L, Pierani P, et al. Prognostic role of minimal residual disease in mature B-cell acute lymphoblastic leukemia of childhood. J Clin Oncol. 2007;25(33):5254\u201361.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2863_CR27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pbc.20121","volume":"44","author":"A Attarbaschi","year":"2005","unstructured":"Attarbaschi A, Dworzak M, Steiner M, Urban C, Fink FM, Reiter A, et al. Outcome of children with primary resistant or relapsed non-Hodgkin lymphoma and mature B-cell leukemia after intensive first-line treatment: a population-based analysis of the Austrian Cooperative Study Group. Pediatr Blood Cancer. 2005;44(1):70\u20136.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"2863_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/pbc.21823","volume":"52","author":"B Stark","year":"2009","unstructured":"Stark B, Avigad S, Luria D, Manor S, Reshef-Ronen T, Avrahami G, et al. Bone marrow minimal disseminated disease (MDD) and minimal residual disease (MRD) in childhood T-cell lymphoblastic lymphoma stage III, detected by flow cytometry (FC) and real-time quantitative polymerase chain reaction (RQ-PCR). Pediatr Blood Cancer. 2009;52(1):20\u20135.","journal-title":"Pediatr Blood Cancer"},{"issue":"22","key":"2863_CR29","doi-asserted-by":"publisher","first-page":"4532","DOI":"10.1200\/JCO.2004.02.121","volume":"22","author":"YE Lieskovsky","year":"2004","unstructured":"Lieskovsky YE, Donaldson SS, Torres MA, Wong RM, Amylon MD, Link MP, et al. High-dose therapy and autologous hematopoietic stem-cell transplantation for recurrent or refractory pediatric Hodgkin\u2019s disease: results and prognostic indices. J Clin Oncol. 2004;22(22):4532\u201340.","journal-title":"J Clin Oncol"},{"issue":"11","key":"2863_CR30","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1016\/j.bbmt.2015.07.032","volume":"21","author":"NS Majhail","year":"2015","unstructured":"Majhail NS, Farnia SH, Carpenter PA, Champlin RE, Crawford S, Marks DI, et al. Indications for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2015;21(11):1863\u20139.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"2863_CR31","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.bbmt.2009.09.021","volume":"16","author":"TG Gross","year":"2010","unstructured":"Gross TG, Hale GA, He W, Camitta BM, Sanders JE, Cairo MS, et al. Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents. Biol Blood Marrow Transplant. 2010;16(2):223\u201330.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"2863_CR32","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/bjh.13040","volume":"167","author":"S Goldman","year":"2014","unstructured":"Goldman S, Smith L, Galardy P, Perkins SL, Frazer JK, Sanger W, et al. Rituximab with chemotherapy in children and adolescents with central nervous system and\/or bone marrow-positive Burkitt lymphoma\/leukaemia: a Children\u2019s Oncology Group Report. Br J Haematol. 2014;167(3):394\u2013401.","journal-title":"Br J Haematol"},{"issue":"9","key":"2863_CR33","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1200\/JCO.2003.08.151","volume":"21","author":"K Seidemann","year":"2003","unstructured":"Seidemann K, Tiemann M, Lauterbach I, Mann G, Simonitsch I, Stankewitz K, et al. Primary mediastinal large B-cell lymphoma with sclerosis in pediatric and adolescent patients: treatment and results from three therapeutic studies of the Berlin-Frankfurt-Munster Group. J Clin Oncol. 2003;21(9):1782\u20139.","journal-title":"J Clin Oncol"},{"issue":"3","key":"2863_CR34","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1182\/blood-2004-03-0973","volume":"105","author":"W Woessmann","year":"2005","unstructured":"Woessmann W, Seidemann K, Mann G, Zimmermann M, Burkhardt B, Oschlies I, et al. The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95. Blood. 2005;105(3):948\u201358.","journal-title":"Blood"},{"issue":"2","key":"2863_CR35","doi-asserted-by":"publisher","first-page":"e26855","DOI":"10.1002\/pbc.26855","volume":"65","author":"M Pillon","year":"2018","unstructured":"Pillon M, Carraro E, Mussolin L, Conter V, Tondo A, Arico M, et al. Primary mediastinal large B-cell lymphoma: outcome of a series of pediatric patients treated with high-dose methotrexate and cytarabine plus anti-CD20. Pediatr Blood Cancer. 2018;65(2):e26855.","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"2863_CR36","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/bjh.14951","volume":"179","author":"L Giulino-Roth","year":"2017","unstructured":"Giulino-Roth L, O'Donohue T, Chen Z, Bartlett NL, LaCasce A, Martin-Doyle W, et al. Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R. Br J Haematol. 2017;179(5):739\u201347.","journal-title":"Br J Haematol"},{"issue":"5","key":"2863_CR37","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/sj.bmt.1701596","volume":"23","author":"R Fanin","year":"1999","unstructured":"Fanin R, de Elvira MR, Sperotto A, Baccarani M, Goldstone A. Autologous stem cell transplantation for T and null cell CD30-positive anaplastic large cell lymphoma: analysis of 64 adult and paediatric cases reported to the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 1999;23(5):437\u201342.","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2863_CR38","doi-asserted-by":"publisher","first-page":"djt378","DOI":"10.1093\/jnci\/djt378","volume":"106","author":"C Gambacorti Passerini","year":"2014","unstructured":"Gambacorti Passerini C, Farina F, Stasia A, Redaelli S, Ceccon M, Mologni L, et al. Crizotinib in advanced, chemoresistant anaplastic lymphoma kinase-positive lymphoma patients. J Natl Cancer Inst. 2014;106(2):djt378.","journal-title":"J Natl Cancer Inst"},{"issue":"25","key":"2863_CR39","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1182\/blood-2017-05-780049","volume":"130","author":"B Pro","year":"2017","unstructured":"Pro B, Advani R, Brice P, Bartlett NL, Rosenblatt JD, Illidge T, et al. Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma. Blood. 2017;130(25):2709\u201317.","journal-title":"Blood"},{"issue":"9475","key":"2863_CR40","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1016\/S0140-6736(05)66659-7","volume":"365","author":"KS Peggs","year":"2005","unstructured":"Peggs KS, Hunter A, Chopra R, Parker A, Mahendra P, Milligan D, et al. Clinical evidence of a graft-versus-Hodgkin\u2019s-lymphoma effect after reduced-intensity allogeneic transplantation. Lancet. 2005;365(9475):1934\u201341.","journal-title":"Lancet"},{"issue":"9980","key":"2863_CR41","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/S0140-6736(15)60165-9","volume":"385","author":"CH Moskowitz","year":"2015","unstructured":"Moskowitz CH, Nademanee A, Masszi T, Agura E, Holowiecki J, Abidi MH, et al. Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin\u2019s lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2015;385(9980):1853\u201362.","journal-title":"Lancet"},{"issue":"19","key":"2863_CR42","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1200\/JCO.2016.72.1316","volume":"35","author":"R Chen","year":"2017","unstructured":"Chen R, Zinzani PL, Fanale MA, Armand P, Johnson NA, Brice P, et al. Phase II study of the efficacy and safety of pembrolizumab for relapsed\/refractory classic Hodgkin lymphoma. J Clin Oncol. 2017;35(19):2125\u201332.","journal-title":"J Clin Oncol"},{"issue":"10","key":"2863_CR43","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1200\/JCO.1991.9.10.1871","volume":"9","author":"DE Reece","year":"1991","unstructured":"Reece DE, Barnett MJ, Connors JM, Fairey RN, Fay JW, Greer JP, et al. Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin\u2019s disease. J Clin Oncol. 1991;9(10):1871\u20139.","journal-title":"J Clin Oncol"},{"issue":"7","key":"2863_CR44","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1038\/bjc.1997.178","volume":"75","author":"C Rubio","year":"1997","unstructured":"Rubio C, Hill ME, Milan S, O'Brien ME, Cunningham D. Idiopathic pneumonia syndrome after high-dose chemotherapy for relapsed Hodgkin\u2019s disease. Br J Cancer. 1997;75(7):1044\u20138.","journal-title":"Br J Cancer"},{"issue":"6","key":"2863_CR45","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3109\/10428194.2011.654341","volume":"53","author":"BG Till","year":"2012","unstructured":"Till BG, Madtes DK. BCNU-associated pneumonitis: portrait of a toxicity. Leuk Lymphoma. 2012;53(6):1019\u201320.","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"2863_CR46","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.3109\/10428194.2011.645208","volume":"53","author":"AA Lane","year":"2012","unstructured":"Lane AA, Armand P, Feng Y, Neuberg DS, Abramson JS, Brown JR, et al. Risk factors for development of pneumonitis after high-dose chemotherapy with cyclophosphamide, BCNU and etoposide followed by autologous stem cell transplant. Leuk Lymphoma. 2012;53(6):1130\u20136.","journal-title":"Leuk Lymphoma"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-020-02863-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-020-02863-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-020-02863-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:38:59Z","timestamp":1744177139000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-020-02863-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,26]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["2863"],"URL":"https:\/\/doi.org\/10.1007\/s12185-020-02863-4","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,26]]},"assertion":[{"value":"5 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}